Healthium Medtech and the Centre for Cellular and Molecular Platforms (C-CAMP) have recently launched the first cohort of the C-CAMP Healthium Innovations Programme for Surgical Interventions and Medical Technologies in Bengaluru.
This programme is a part of the CSR initiative of Healthium Medtech. The partnership aims to foster deep-science innovations in digitally enabled medical technologies that are affordable, scalable and clinically impactful.
In its first year, the initiative focuses on surgical interventions, an area undergoing rapid modernisation globally but still marked by limited access and affordability across large parts of India.
Despite the increasing adoption of advanced surgical technologies in metropolitan hospitals, smaller healthcare systems in Tier 2 and Tier 3 cities often remain underserved. The high cost of imported solutions, along with infrastructure and training gaps, have made it difficult to scale access to modern surgical care. This program was created to address these challenges by nurturing India-led, frugal and scalable innovations that are tailored for local needs without compromising on quality or outcomes.
The initiative brings together two organisations with complementary strengths. Healthium Medtech brings deep expertise in surgical and post-surgical technologies, supported by a diverse product portfolio and robust manufacturing capabilities. The company operates 6 facilities with global certifications and holds over 85 patents across India, the US and Europe. C-CAMP, an initiative supported by the Department of Biotechnology, Government of India, has built one of the country’s leading life sciences innovation ecosystems, having supported over 550 deep-tech start-ups across domains and connected with 3000 more.
Together, the collaboration combines clinical insight, market access and ecosystem support to help early-stage ventures overcome critical barriers from research to commercialisation.
Over the next nine months, the selected startups will receive structured mentorship and incubation support at C-CAMP and access to clinical and industry expertise to help advance their technologies toward market readiness and adoption.
